Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Starbucks, Raises Price Target to $96

Morgan Stanley Maintains Equal-Weight on Starbucks, Raises Price Target to $96

Morgan Stanley analyst John Glass maintains Starbucks (NASDAQ:SBUX) with a Equal-Weight and raises the price target from $88 to $96.

byBenzinga Newsdesk

September 15, 2022

1 minute read

Morgan Stanley analyst John Glass maintains Starbucks (NASDAQ:SBUX) with a Equal-Weight and raises the price target from $88 to $96.

Analyst Ratings

What 5 Analyst Ratings Have To Say About Berry Global Gr

By Benzinga Insights

July 11, 12:00 PM

Berry Global Gr (NYSE:BERY) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

BERY

Nike Shares Tank After Q2 Earnings: ‘Reduced Guidance Implies Ongoing Uncertainty’

By Priya Nigam

December 22, 1:16 PM

Nike Inc (NYSE: NKE) shares are tanking Thursday after the company reported softer-than-expected revenue guidance for its fiscal second quarter</

NKE

Analyst Ratings

Analyst Expectations for Pacific Biosciences’s Future

By Benzinga Insights

August 22, 2:00 PM

Analysts have provided the following ratings for Pacific Biosciences (NASDAQ:PACB) within the last quarter: Bullish Somewhat Bullish Indifferent…

PACB

BMO Capital Upgrades Fate Therapeutics to Outperform, Lowers Price Target to $47

By Benzinga Newsdesk

July 12, 7:47 AM

BMO Capital analyst Etzer Darout upgrades Fate Therapeutics (NASDAQ:FATE) from Market Perform to Outperform and lowers the price target from $50 to $47.

FATE

Morgan Stanley Maintains Equal-Weight on Starbucks, Raises Price Target to $96

Related Posts

What 5 Analyst Ratings Have To Say About Berry Global Gr

Nike Shares Tank After Q2 Earnings: ‘Reduced Guidance Implies Ongoing Uncertainty’

Analyst Expectations for Pacific Biosciences’s Future

BMO Capital Upgrades Fate Therapeutics to Outperform, Lowers Price Target to $47